Latest Breaking News On - Vaccitech plc - Page 7 : comparemela.com

By Reuters Staff 2 Min Read FILE PHOTO: Vials of Oxford/AstraZeneca s COVID-19 vaccine are pictured at a vaccination centre in Bierset, Belgium March 17, 2021. REUTERS/Yves Herman/File Photo (Reuters) - Biotech startup Vaccitech Plc, which owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca Plc, filed for a U.S. initial public offering on Friday. The British company plans to list the American depositary shares on the Nasdaq under the symbol “VACC”. Vaccitech’s revenue dropped about 30% to $4.8 million in the year ended Dec. 31, even as its net loss narrowed to $17.9 million from $22.7 million due to lower research and development expenses.

United statesUnited kingdomCity ofSarah gilbertVinay dwivediPraveen paramasivamThomson reuters trust principlesMorgan stanleyVaccitech plcAstrazeneca plcOxford universityThomson reuters trustஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்நகரம் ஆஃப்சாரா கில்பர்ட்